Novartis Ag (NVS) Current Leases (2019 - 2025)

Novartis Ag's Current Leases history runs 7 years deep, the most recent figure standing at $263.0 million for Q4 2025.

• In Q4 2025, Current Leases rose 11.91% year-over-year to $263.0 million; the TTM figure through Dec 2025 stood at $263.0 million (up 11.91% YoY), while the FY2025 annual figure was $263.0 million, up 11.91% from the prior year.
• Current Leases came in at $263.0 million for Q4 2025 at Novartis Ag, up from $235.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $275.0 million in Q4 2021 to a low of $230.0 million in Q4 2023.
• A 5-year average of $250.8 million and a median of $251.0 million in 2022 frame the typical range for Current Leases.
• Across the five-year window, Current Leases retreated 8.73% in 2022 and rose 11.91% in 2025, its largest moves.
• Novartis Ag's Current Leases stood at $275.0 million in 2021, then declined by 8.73% to $251.0 million in 2022, then declined by 8.37% to $230.0 million in 2023, then rose by 2.17% to $235.0 million in 2024, then grew by 11.91% to $263.0 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $263.0 million, $235.0 million, and $230.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison